自己免疫疾患の世界市場:疾患別(限局性、全身性)、診断別(IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他)、製品別(医薬品、治療・モニター機器、診断機器)、地域別予測

◆英語タイトル:Global Autoimmune Disease Market Size study, by Disease Type (Localized, Systemic), by Diagnostic (IFA, ELISA, Dot blot, Line Blot, Agglutination, Double Immune Diffusion, Western Blotting, Multiplex Immunoassay, Others), by Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment) and Regional Forecasts 2018-2025
◆商品コード:BZW9JN015
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2018年12月31日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥422,650見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥593,850見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、自己免疫疾患の世界市場について調べ、自己免疫疾患の世界規模、市場動向、市場環境、疾患別(限局性、全身性)分析、診断別(IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他)分析、製品別(医薬品、治療・モニター機器、診断機器)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはAbbott Laboratories、Active Biotech、Eli Lilly、Bristol-Myers Squibb、AstraZeneca plc、Pfizer、Biogen Idec、Lupin Limited、GlaxoSmithKline、Amgen、4SC、F. Hoffmann-La Roche Ltd.、AutoImmune Inc.、Johnson & Johnson、Bayerなどです。
・イントロダクション
・エグゼクティブサマリー
・自己免疫疾患の世界市場概要
・自己免疫疾患の世界市場環境
・自己免疫疾患の世界市場動向
・自己免疫疾患の世界市場規模
・自己免疫疾患の世界市場規模:疾患別(限局性、全身性)
・自己免疫疾患の世界市場規模:診断別(IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他)
・自己免疫疾患の世界市場規模:製品別(医薬品、治療・モニター機器、診断機器)
・自己免疫疾患の世界市場:地域別市場規模・分析
・自己免疫疾患の北米市場規模・予測
・自己免疫疾患のアメリカ市場規模・予測
・自己免疫疾患のヨーロッパ市場規模・予測
・自己免疫疾患のアジア市場規模・予測
・自己免疫疾患の日本市場規模・予測
・自己免疫疾患の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Autoimmune Disease Market to reach USD XX billion by 2025.

Global Autoimmune Disease Market valued approximately USD 37.81 billion in 2017 is anticipated to grow with a healthy growth rate of more than 3.82% over the forecast period 2018-2025. The Autoimmune Disease Market is continuously growing in global scenario over the coming years. The major driving factor of global Autoimmune Disease market is increasing incidence of chronic diseases and development of novel biomarkers such as Enbrel & Humira. In addition, improvement in regulatory framework, technological enhancements, and growing government assistance are also some other major factors which propelling the growth of the market. However, High treatment cost, poorly trained physicians and emergence of alternative technologies are some major factors which limiting the market growth. Autoimmune disease is a condition in which immune system mistakenly attacks body. These diseases cause dissimilarities in organ functioning, anomalous growth of organs and destruction of vigorous body. These disease are habitually chronic in nature and there is no remedial therapy. The common autoimmune diseases are Type 1 diabetes, Rheumatoid arthritis, Psoriasis/Psoriatic arthritis, Multiple sclerosis, Systemic lupus erythematous (lupus), Inflammatory bowel diseases, Myasthenia gravis, Vasculitis, Celiac disease and so on. Various types of treatment for theses diseases include physical therapy, blood transfusion, recombinant technology, chemo therapy, topical therapy, TNF-a antagonists and Helminthic.
The regional analysis of Global Autoimmune Disease Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing investment in R&D and increasing awareness among people related to healthcare. Europe is also estimating to project a major growth in the global Autoimmune Disease market due to increasing disposable income of individuals in the region. Asia-Pacific is also anticipated to exhibit higher growth rate/CAGR over the forecast period 2018-2025 due to improving health infrastructure and increasing aging population.
The major market player included in this report are:
• Abbott Laboratories
• Active Biotech
• Eli Lilly
• Bristol-Myers Squibb
• AstraZeneca plc
• Pfizer
• Biogen Idec
• Lupin Limited
• GlaxoSmithKline
• Amgen
• 4SC
• F. Hoffmann-La Roche Ltd.
• AutoImmune Inc.
• Johnson & Johnson
• Bayer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

 Localized
 Systemic

By Diagnostic:

 IFA
 ELISA
 Dot blot
 Line Blot
 Agglutination
 Double Immune Diffusion
 Western Blotting
 Multiplex Immunoassay
 Others

By Product:

 Drugs
 Therapeutic & Monitoring Equipment
 Diagnostic Equipment

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Autoimmune Disease Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Autoimmune Disease Market, by Disease Type, 2015-2025 (USD Billion)
1.3.2. Autoimmune Disease Market, by Diagnostics, 2015-2025 (USD Billion)
1.3.3. Autoimmune Disease Market, by Products, 2015-2025 (USD Billion)
1.3.4. Autoimmune Disease Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Autoimmune Disease Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Autoimmune Disease Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Autoimmune Disease Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. Autoimmune Disease Market, by Disease Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Autoimmune Disease Market, Sub Segment Analysis
5.4.1. Localized
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Systemic
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Autoimmune Disease Market, by Diagnostics
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Autoimmune Disease Market, Sub Segment Analysis
6.4.1. IFA
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. ELISA
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Dot blot
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Line blot
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5. Agglutination
6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6. Double Immune Diffusion
6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.7. Western Blotting
6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.8. Multiplex Immunoassay
6.4.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.9. Others
6.4.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Autoimmune Disease Market, by Product
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Key Market Players
7.4. Autoimmune Disease Market, Sub Segment Analysis
7.4.1. Drugs
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. Therapeutic & Monitoring Equipment
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Diagnostic Equipment
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Autoimmune Disease Market, by Regional Analysis
8.1. Autoimmune Disease Market, Regional Market Snapshot (2015-2025)
8.2. North America Autoimmune Disease Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Autoimmune Disease Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. France
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Rest of Europe
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Autoimmune Disease Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Autoimmune Disease Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Active Biotech
9.3.3. Eli Lilly
9.3.4. Bristol-Myers Squibb
9.3.5. AstraZeneca plc
9.3.6. Pfizer
9.3.7. Biogen Idec
9.3.8. Lupin Limited
9.3.9. GlaxoSmithKline
9.3.10. Amgen
9.3.11. 4SC
9.3.12. F. Hoffmann-La Roche Ltd.
9.3.13. AutoImmune Inc.
9.3.14. Johnson & Johnson
9.3.15. Bayer
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF AUTOIMMUNE DISEASE MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF AUTOIMMUNE DISEASE MARKET
TABLE 3. AUTOIMMUNE DISEASE MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. AUTOIMMUNE DISEASE MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. AUTOIMMUNE DISEASE MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. AUTOIMMUNE DISEASE MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF AUTOIMMUNE DISEASE MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF AUTOIMMUNE DISEASE MARKET
TABLE 3. AUTOIMMUNE DISEASE MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. AUTOIMMUNE DISEASE MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. AUTOIMMUNE DISEASE MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. AUTOIMMUNE DISEASE MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. AUTOIMMUNE DISEASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. AUTOIMMUNE DISEASE MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW AUTOIMMUNE DISEASE MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

【掲載企業】

Abbott Laboratories、Active Biotech、Eli Lilly、Bristol-Myers Squibb、AstraZeneca plc、Pfizer、Biogen Idec、Lupin Limited、GlaxoSmithKline、Amgen、4SC、F. Hoffmann-La Roche Ltd.、AutoImmune Inc.、Johnson & Johnson、Bayer

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[自己免疫疾患の世界市場:疾患別(限局性、全身性)、診断別(IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他)、製品別(医薬品、治療・モニター機器、診断機器)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆